VOCAL FOLD INFUSION NEEDLE
Report
- Report Number
- 1225968-2007-00001
- Event Type
- Other
- Date Received
- November 21, 2007
- Date of Event
- October 19, 2007
- Report Date
- November 20, 2007
- Manufacturer
- ENDOCRAFT LLC.
- Product Code
- KAA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- NURSE
Narratives
THE 'VOCAL FOLD INFUSION NEEDLE' WAS DESIGNED TO BE USED SOLELY FOR THE VOCAL FOLD THROUGH A DIRECT LARYNGOSCOPE AND WITH MAGNIFICATION PROVIDED BY A SURGICAL MICROSCOPE. FOR A NUMBER OF REASONS, IT IS NOT SAFE TO USE AN ANGLED LARYNGEAL NEEDLE IN OTHER SITES SUCH AS THE ESOPHAGUS, WHICH IS EXACTLY WHAT WAS DONE IN THIS CASE. AS YOU WILL NOTE IN THE DIAGRAMS IN THE INSTRUCTIONS-FOR-USE THAT ACCOMPANIED THE NEEDLES, ONLY THE DISTAL ANGLED 3MM TIP OF THE NEEDLE SHOULD HAVE BEEN PENETRATING THE TISSUE SO THAT ANY FORCE-RELATED BENDING SHOULD HAVE BEEN OBVIOUS WHILE VIEWING THROUGH THE SURGICAL MICROSCOPE. THEREFORE, THE SURGEON SHOULD HAVE SEEN THE NEEDLE IF IT WAS BENDING OR BREAKING. FURTHERMORE, EVEN IF THE EXCESSIVE FORCE-RELATED BENDING WAS MISSED AND THE NEEDLE FRACTURED FROM THE SHAFT, IT SHOULD HAVE BEEN SIMPLE TO REMOVE THE NEEDLE. SINCE ONLY THE DISTAL ANGLED ASPECT OF THE NEEDLE SHOULD HAVE BEEN IN THE SOFT TISSUE, THE PROXIMAL ASPECT OF THE NEEDLE WOULD HAVE BEEN EASILY SEEN EMANATING FROM THE SURGEON'S PUNCTURE SITE. THE OPERATING NURSE EXPLAINED THAT SHE WAS SURPRISED AT THEIR CURRENT SCENARIO EXPLAINING THAT NO ONE AT THEIR INSTITUTION HAD PRIOR DIFFICULTIES WITH THE VOCAL FOLD INFUSION NEEDLES. IN FACT, THIS IS THE FIRST INDICATION OF A PROBLEM THAT ENDOCRAFT HAS HEARD ABOUT.
THE OPERATING NURSE CONTACTED US AND INDICATED THAT DR HAD BROKEN A VOCAL FOLD INFUSION NEEDLES FROM ITS SHAFT WHILE USING IT TO INJECT THE ESOPHAGUS OF A PT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | VOCAL FOLD INFUSION NEEDLE | LARYNGEAL INJECTING DEVICE | KAA | ENDOCRAFT LLC. | UMG 100A | 110205 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | YR | Required Intervention |